Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world... more
FAQs about Audio Journal of Oncology Podcast:How many episodes does Audio Journal of Oncology Podcast have?The podcast currently has 192 episodes available.
August 28, 2025Laura J. van 't Veer, PhDImPrintTN single-sample classifier identifies no benefit from deoadjuvant pembroliozumab in TNBC...more16minPlay
August 22, 2025Érica A. Oliveira PhD: How to Overcome Drug Resistance: Patient Derived Organoids Study Finds Epigenetic Pathways in Colorectal CancerPatient Derived Organoids Shine a Light on Epigenetic Archetypes as Key Drivers of Cancer Drug ResistanceLONDON, UK—How to stay ahead with treatment as cancer cells evolve to evade therapies and regi...more25minPlay
August 05, 2025Christian Singer MD: Neoadjuvant Olaparib Combination Beats Standard of Care in Patients with Homologous Recombination Deficient BRCA 1/2-Positive Triple-Negative Breast CancerHomologous Repair Deficient Triple Negative Breast Cancer Positive for BRCA1/2 Mutations Better with Neoadjuvant Olaparib + Carboplatin...more11minPlay
July 18, 2025Erica L. Mayer MD MPH: Adjuvant Abemaciclib: Start Low, then Dose Escalate in Early-stage HR+/HER2- Breast Cancer: TRADE Study FindingsInterview with Erica L. Mayer MD MPH, Director of Breast Cancer Clinical Research, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA. With comment from: Pat Price MD, Imperial College...more10minPlay
July 12, 2025Patients with Early-Stage Non-Squamous Non-Small Cell Lung Cancer Who can Benefit from Adjuvant ChemotherapyAn interview with: David R Spigel FASCO, MD, Chief Scientific Officer, Sarah Cannon Research Institute, Nashville, Tennessee, US With comment from: Luis G Paz-Ares MD PhD Chair of Medical Oncology, Ho...more12minPlay
July 03, 2025Adjuvant Nivolumab Extends Disease-Free Survival in Patients with High-Risk Head and Neck Cancers“Adjuvant nivolumab added to chemoradiotherapy after surgery provided a statistically and clinically meaningful disease-free survival improvement in PD-L1 all-comers patients. This is the first time i...more10minPlay
June 30, 2025Luis G Paz-Ares MD PhDLuis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)...more12minPlay
June 19, 2025Elena Elez, Barcelona, ASCO: BRAF Inhibitor Encorafenib Delays Progression, Extends Survival in Patients with Inoperable BRAF V600E Mutant Colorectal CancerAn interview with: Elena Elez MD PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain CHICAGO, USA—Adding the BRAF inhibitor encorafenib (partnered with EGFR-inhibitor cetuximab) to standa...more16minPlay
June 17, 2025Yelena Y. Janjigian MDYelena Y. Janjigian MD says that perioperative anti-PD-L1 immunotherapy with durvalumab was a “game changer” meriting use as a new standard of care when used together with chemotherapy to...more5minPlay
June 12, 2025Christopher Booth MD: Post-Surgery Exercise Therapy Reduced Recurrence Risk and Extended Life in Patients with Colon CancerExercise was as good as the addition of a drug among patients with high risk stage 2 or stage 3 colon cancer after curative surgery, extending life and preventing cancer recurrence. Christopher Booth...more11minPlay
FAQs about Audio Journal of Oncology Podcast:How many episodes does Audio Journal of Oncology Podcast have?The podcast currently has 192 episodes available.